Recursion Pharmaceuticals, Inc. - RXRX

About Gravity Analytica
Recent News
- 02.28.2025 - Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results
- 02.28.2025 - Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results
- 02.24.2025 - Recursion to Report Fourth Quarter and Fiscal Year 2024 Business Updates and Financial Results on February 28th
- 02.24.2025 - Recursion to Report Fourth Quarter and Fiscal Year 2024 Business Updates and Financial Results on February 28th
- 02.19.2025 - Altitude Lab Launches Pre-seed Venture Fund, Anchored by Recursion CEO Chris Gibson, Enabling SBIR-awarded Biotechs Hit by Funding Gap to Build in Salt Lake City
- 02.19.2025 - Altitude Lab Launches Pre-seed Venture Fund, Anchored by Recursion CEO Chris Gibson, Enabling SBIR-awarded Biotechs Hit by Funding Gap to Build in Salt Lake City
- 02.18.2025 - Altitude Lab Startups Raise $154M in Capital
- 02.18.2025 - Altitude Lab Startups Raise $154M in Capital
- 02.05.2025 - Recursion Presents Phase 2 Data for REC-994 in CCM in Late-Breaking Oral Presentation at the International Stroke Conference
- 02.05.2025 - Recursion Presents Phase 2 Data for REC-994 in CCM in Late-Breaking Oral Presentation at the International Stroke Conference
Recent Filings
- 02.20.2025 - 4 Statement of changes in beneficial ownership of securities
- 02.20.2025 - 4 Statement of changes in beneficial ownership of securities
- 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 02.12.2025 - S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
- 02.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
- 02.06.2025 - 144 Report of proposed sale of securities
- 02.05.2025 - 144 Report of proposed sale of securities
- 02.05.2025 - 4 Statement of changes in beneficial ownership of securities